Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS Sign Language expert appointed to a national government committee
2010-05-13

Photo: Mangaliso Radebe


The National Department of Basic Education has appointed the Head of the Department of Afro-Asiatic Studies, Sign Language and Language Practice at the University of the Free State (UFS), Mr Philemon Akach, to serve in its Curriculum Management Team.

“It is my pleasure to inform you that you have been appointed as a member of the Curriculum Management Team to manage the development of Sign Language as a subject to be listed in the National Curriculum Statement Grades R-12,” the Minister of Basic Education, Mrs Angie Motshekga, wrote in her letter to Mr Akach.

“I am excited, after mulling over this, saying that maybe this time around it may just work because, from experience, I can sensitise the other committee members on how to build in an implementation strategy right from the beginning,” said Mr Akach.

“Over the last 12 years we have implemented the proposed part of the curriculum for tertiary institutions at this university, so our input will be a practical one. We have not only theoretically proven it can be done but have developed multimedia teaching materials as a legacy to sustain the course as a permanent feature at this level. I will share this with the management to implement what is already working.”

He was a Director of Sign Language and Interpreting Development with the Deaf Federation of South Africa for three years (1996-1998). During that time he directed the development of the South African Sign Language (SASL) curriculum as a school subject from Grades 0-12, as well as SASL as a second language, and a proposal to tertiary institutions on what they should take note of, should they considered introducing SASL as an academic course. All of these were handed over to the Department of Education in 1997.

“Committees are a good tool to write proposals but if there is no policing of the implementation, not much seems to work,” he said.

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
12 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept